Publications in collaboration with researchers from Ifakara Health Institute (18)

2021

  1. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?

    PLoS Neglected Tropical Diseases, Vol. 15, Núm. 3

  2. Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain

    Signal Transduction and Targeted Therapy, Vol. 6, Núm. 1

  3. Human botfly infestation in an amerindian girl in Southern Venezuela

    American Journal of Tropical Medicine and Hygiene

  4. Malaria in Venezuela: Gabaldón's legacy scattered to the winds

    The Lancet Global Health

  5. Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing

    Frontiers in Pharmacology, Vol. 12

  6. Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study

    Parasites and Vectors, Vol. 14, Núm. 1

  7. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

    EClinicalMedicine, Vol. 32

  8. The effect of ivermectin alone and in combination with cobicistat or elacridar in experimental Schistosoma mansoni infection in mice

    Scientific Reports, Vol. 11, Núm. 1

  9. The malaria burden of Amerindian groups of three Venezuelan states: a descriptive study based on programmatic data

    Malaria Journal, Vol. 20, Núm. 1

  10. The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes

    PLoS Pathogens, Vol. 17, Núm. 3

2020

  1. A roadmap for the development of ivermectin as a complementary malaria vector control tool

    American Journal of Tropical Medicine and Hygiene, Vol. 102, pp. 3-24

  2. Ivermectin and COVID-19: Keeping rigor in times of urgency

    American Journal of Tropical Medicine and Hygiene

  3. Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study

    The Lancet Infectious Diseases, Vol. 20, Núm. 4, pp. 498-508

  4. Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats

    Scientific Reports, Vol. 10, Núm. 1

  5. Update on malaria

    Medicina Clinica, Vol. 155, Núm. 9, pp. 395-402